1Gender dysphoria
the distress experienced when a person's gender identity is not the same as their gender assigned at birth
2What is the treatment for gender dysphoria?
help people to live in their preferred gender
3What is the treatment pathway?
•Referral by GP to gender specialist or gender identity specialist clinic
•Confirmation of gender dysphoria by a multi-disciplinary team
•If appropriate, hormone therapy
•Oestrogen and anti-androgens for Male to Female (MtF)
•Testosterone for Female to Male (FtM)
•Gonadotrophin-releasing hormone analogue (GnRH) to block puberty in children
4What therapies can be given?
•Mental Health Support
•Hair removal (if required)
•Speech and language therapy
Surgery
5Explain the treatment for children and young people
•Referral to gender identity development clinic (GIDS) for assessment (3-6 months)
Initially psychological treatment (e.g. psychotherapy, family therapy, parental support
•puberty blockers might be considered to pause sexual development.
•From 16 years of ages, cross-sex hormones might be considered if have used puberty blockers for at least 12 months.
6What can cross-sex hormones cause?
Irreversible changes (e.g. breast development, voice deepening) and can lead to infertility
7What hormones are given for trans a man?
Parenteral/transdermal testosterone
8What does the testosterone result in?
•More body and facial hair
•More muscle
•Periods stop
•Increased libido
•Voice may become deeper
9What hormones are given for trans a woman?
Oestrogen: Estradiol (oral, transdermal patches) or estradiol(parenteral)
•Anti-androgens: cyproterone acetate, spironolactone
10What do oestrogens and anti-androgens result in?
•Genital shrinkage
•Less muscle
•Fat on hips
•Lumpy and enlarged breasts
•Less facial and body hair
11What are the adverse outcomes of hormone therapy in transgender female?
•Very high risk:
•Thrombosis
•Moderate risk:
•Breast cancer
•Stroke
•Coronary artery disease
•Hypertriglyceridemia
•Pituitary adenoma (benign)
•Gall stones
12What are the adverse outcomes of hormone therapy in transgender male?
•Very high risk:
•Increased RBC volume
•Moderate risk:
•Severe liver dysfunction
•Stroke
•Coronary artery disease
•Hypertension
•Breast or uterine cancer